Temporomandibular Disorder in Use of Levonorgestrel Intrauterine System

Launched by MARMARA UNIVERSITY · Jul 12, 2024

Keywords

ClinConnect Summary

This clinical trial is looking into whether using the levonorgestrel intrauterine system (IUS), a type of birth control device, might be linked to problems with the jaw joint, known as temporomandibular joint disorder (TMD). The researchers want to compare two groups of women: one group who have used the IUS for at least three months and another group of healthy women who do not use any medications and have regular menstrual cycles. Both groups consist of women aged 18 to 50.

To participate in the study, women must be in generally good health and have been using the IUS. However, some women will not be eligible, such as those who have had injuries to the head or neck, certain joint disorders, or other specific health issues. Participants will help researchers understand if there’s a connection between the IUS and TMD, which could lead to better care for women experiencing these symptoms. If you decide to join, you'll be contributing to important research while receiving care and support throughout the trial.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Being a woman
• • Having used an intrauterine device for at least 3 months
• • Being between the ages of 18-50
• • Being in American Society of Anesthesiologists-1 and American Society of Anesthesiologists-2 systemic status
• Exclusion Criteria:
• • Patients with craniofacial syndrome
• • Patients with a history of head and neck trauma
• • Isolated muscle tenderness or previous surgery on TMJ
• • Patients with rheumatological disorders
• • Patients with an additional gynecological disease other than endometriosis
• • Lack of cooperation with the patient.